Explore By Subject Area   
Return Home
Menu

Lead Editorial

Conference Forum Joins Fierce Life Sciences

Conference Forum Joins Fierce Life Sciences

The Conference Forum has been acquired by Questex LLC, the parent company of Fierce Healthcare & Life Sciences.

Read More

Featured Editorial

How Merck Research Labs Is Evolving its Global Clinical Supply to Meet the Demands of Newer Modalities

Read More

Biogen on Digital Innovations to Increase Trial Access and Enhance Patient Experiences

Read More

What Clinical Research Means to Patients in Ukraine, and How Industry Sponsors Can Help

Read More

How CMOs can Leverage AI to Streamline Clinical Development

Read More

TrialHub Wins DPHARM Idol Disrupt 2025

Read More

Editorial by Category

Modernizing Clinical Trial Operations

View All
Editor's Pick: How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
Editor's Pick: How Memorial Sloan Kettering Cancer Center Scaled EHR-to-EDC Technology
Editor's Pick: The Small Pharma Approach to Innovation, with Kyowa Kirin
Editor's Pick: The Small Pharma Approach to Innovation, with Kyowa Kirin
How the Next Generation of Clinical Operations Workforce is Evolving, with Jazz Pharmaceuticals
How the Next Generation of Clinical Operations Workforce is Evolving, with Jazz Pharmaceuticals
How Biogen Acts on Patient Feedback
How Biogen Acts on Patient Feedback

Immuno-Oncology and Cell Therapy

View All
Editor's Pick: Could In Vivo CAR-T Cell Therapy Replace Ex Vivo?
Editor's Pick: Could In Vivo CAR-T Cell Therapy Replace Ex Vivo?
Where AI is Reshaping Imaging for Oncology Drug Development
Where AI is Reshaping Imaging for Oncology Drug Development
Women Leadership in Immuno-Oncology Annual Profile Series: 2026 Edition
Women Leadership in Immuno-Oncology Annual Profile Series: 2026 Edition
Going After Mismatch Repair Deficiency in Solid Tumors for Powerful Tumor Response
Going After Mismatch Repair Deficiency in Solid Tumors for Powerful Tumor Response

Drug Delivery

View All
How BMS is Bringing Patient Friendly Therapies to Market
How BMS is Bringing Patient Friendly Therapies to Market
Nanoform - Subcutaneously Administered Nanotrastuzumab Matches Performance of Herceptin HYLECTA in Minipig Study
Nanoform - Subcutaneously Administered Nanotrastuzumab Matches Performance of Herceptin HYLECTA in Minipig Study
Sanofi’s Partnering Philosophy in Drug Delivery
Sanofi’s Partnering Philosophy in Drug Delivery
Ophthalmic Implants: Current and Future Technologies in Long-Acting Drug Delivery
Ophthalmic Implants: Current and Future Technologies in Long-Acting Drug Delivery

Patients as Partners in Clinical Research and Patient Access

View All
Editor's Pick: How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
Editor's Pick: How Pfizer Is Tackling Patient Insight Continuity Across a Global Organization
Editor's Pick: Operationalizing a New R&D Patient-Centricity Model at J&J
Editor's Pick: Operationalizing a New R&D Patient-Centricity Model at J&J
What Patients and Sites Want, and Don't Want, from Tech in Clinical Trials, from Partnerships with Sites 2025
What Patients and Sites Want, and Don't Want, from Tech in Clinical Trials, from Partnerships with Sites 2025
Questex Presents the 10th Annual Patients as Partners® in Clinical Trials Europe Conference
Questex Presents the 10th Annual Patients as Partners® in Clinical Trials Europe Conference

Biotech CMO/R&D Leadership

View All
Barbara Wirostko on CMO Leadership and Being the First Woman Chair-Elect of the ARVO Foundation
Barbara Wirostko on CMO Leadership and Being the First Woman Chair-Elect of the ARVO Foundation
The Evolving Role of the CMO: Balancing Clinical and Financial Strategy
The Evolving Role of the CMO: Balancing Clinical and Financial Strategy
Questex Announces 2026 Chief Medical Officer Summit 360° Agenda and Keynotes
Questex Announces 2026 Chief Medical Officer Summit 360° Agenda and Keynotes
How Biotech CMOs Can Prepare for M&A with Pharma
How Biotech CMOs Can Prepare for M&A with Pharma

Community-Based Clinical Trials

View All
Editor's Pick: How Sponsors Can Help Sites with Payment, Staffing and Technology
Editor's Pick: How Sponsors Can Help Sites with Payment, Staffing and Technology
Editor's Pick: How Boehringer Ingelheim’s Site Engagement Academy Is Creating Empathetic Site Partnerships
Editor's Pick: How Boehringer Ingelheim’s Site Engagement Academy Is Creating Empathetic Site Partnerships
How AstraZeneca Formed Long-Term Site Relationships to Reduce Site Burden and Optimize Study Start-Up
How AstraZeneca Formed Long-Term Site Relationships to Reduce Site Burden and Optimize Study Start-Up
5 Takeaways on What Makes a Successful Site-Sponsor-CRO Partnership, from Partnerships with Sites 2025
5 Takeaways on What Makes a Successful Site-Sponsor-CRO Partnership, from Partnerships with Sites 2025

Women Leadership in Biotech

View All
Women Leadership in Immuno-Oncology Annual Profile Series: 2026 Edition
Women Leadership in Immuno-Oncology Annual Profile Series: 2026 Edition
Commercializing Therapies Requires Patient-Centricity and Advocacy
Commercializing Therapies Requires Patient-Centricity and Advocacy
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
Staying Passionate about IO’s Potential and Investing in Biotechs Addressing IO’s Toughest Challenges
How Sponsors Can Help Sites with Payment, Staffing and Technology
How Sponsors Can Help Sites with Payment, Staffing and Technology

Subscribe for More Information

Please provide your contact information and select areas of interest to receive updates.